Actionable news
All posts from Actionable news
Actionable news in NVS: NOVARTIS AG,

Novartis Tops Q2 Earnings Estimate, Boosts Alcon Full Year Sales Guidance

Novartis AG (NVS) posted stronger-than-expected second quarter earnings Tuesday and lifted the outlook for full-year sales at its eyecare division

Novartis said earnings per share hit $1.22 in the three months ending in June, firmly ahead of the FactSet compiled consensus of $1.14 but down from the $1.23 generated over the same period last year. Group sales were tabbed at $12.242 billion, Novartis said, down 2% from last year but ahead of analysts's forecasts of 11.83 billion.

JUST UPDATED – TheStreet's Biotech Bible! Before you invest one single dime in any biotech stock you have got to KNOW WHAT YOU ARE BUYING! Get THE...